anti malarials

Upload: vijender-atri

Post on 07-Apr-2018

221 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/4/2019 Anti Malarials

    1/50

    Anti-malarials

  • 8/4/2019 Anti Malarials

    2/50

    Malaria

    Uncomplicated malaria Severe malaria

    Falciparum malariaVivax malaria Falciparum malaria

    Negligence CQ resistance

    Quinine Inj.Artesunate Inj.

    Arteether Inj.Followed byQuinine tab.Arte + Meflo

    Arte + Sulfa & Pyri

    Chloroquine(Oral)

    Amodiaquine

    Artesunate oral,

    Artemether oral,Artemether + LumeArtesunate + MefloArte + Sulfa + Pyri

    Sulfa + Pyri

    Vivax malaria

    CQ Inj.

    Artesunate InjArteether InjCQ tab.

    Artesunate tabSulfa + Pyri

    Artesunate InjArteether Inj.

    Followed byArte + MefloArte + Sulfa

    & Pyri

  • 8/4/2019 Anti Malarials

    3/50

    OpportunitiesArteplus CD/Falcigo/Plus

    CQ in vivax

    Malaria

    Arte-CD

    SP in CQresistantmalaria

    Arte-CD

    CQ in severevivax malaria

    Falcigo/plus

    SP in UC

    Falci.Malaria

    Arte/Fal plus

    Aremetherin UC falci.

    MalariaArte-CD

    Falcigo

    plus

    Arteether inSevere

    MalariaFalcigo

    Falcigo

    plus

    Quinine insevere

    malariaFalcigo

    Falcigo plus

  • 8/4/2019 Anti Malarials

    4/50

    Condition

    Region is endemic for malaria.

    Chloroquine resistant strains of P.vivaxand P.falciparum are seen in the region.

    More cases of malaria were due tofalciparum.

    Many cases were found to be havingmixed infection

  • 8/4/2019 Anti Malarials

    5/50

    Situation 1-

    CQ in vivax malaria

    Patient concern:-

    Patient is having high grade fever withmoderate chills.

    Feeling of weakness

    Loss of appetite

  • 8/4/2019 Anti Malarials

    6/50

    Therapeutic needs

    Faster fever clearance time

    Faster parasite clearance time

    To prevent the infection from becomingsevere.

  • 8/4/2019 Anti Malarials

    7/50

    Focus point

    To normalize the patient as early aspossible.

    Effective treatment of mixed infection dueto vivax/falciparum.

    Control the infection so that it does notbecomes severe.

  • 8/4/2019 Anti Malarials

    8/50

    Call objective

    To convert Chloroquine Rxer to Arteplus/CD in vivax/mixed malaria.

  • 8/4/2019 Anti Malarials

    9/50

    Need identification

    Dr. what are the major challenges you face whiletreating malaria ?

    How difficult it is to find out the causative

    pathogen of malaria when the patient mighthave already taken some treatment ?

    In such cases for better treatment outcome, areyou looking for a drug which can treat both CQresistant vivax/mixed malaria effectively ?

  • 8/4/2019 Anti Malarials

    10/50

    Benefit presentation

    Dr. this article was published in Korean Journal of

    Parasitology, 2007.This study was conducted on 100

    patients suffering from malaria. The patients were given

    Chloroquine and AL.

    Conclusion:- The combination of AL was well tolerated

    by all the patients and was recommended over CQ when

    the possibility of the mixed infection can not be ruled out

    for better treatment outcome.

  • 8/4/2019 Anti Malarials

    11/50

    Feedback

    Dr. looking at the benefits, do you thinkthat Arteplus CD is a better treatmentchoice where possibility of the mixed

    infection can not be ruled out as comparedwith CQ ?

  • 8/4/2019 Anti Malarials

    12/50

    Possible objection

    CQ is more cost effective than AL?

    Dr. I appreciate your concern for thepatients pocket but if you look at the costof lab test and the discomfort which thepatient has to undergo, you will find thatArteplus is more economical than CQ.

  • 8/4/2019 Anti Malarials

    13/50

    Commitment

    Dr. for better treatment outcome inmalaria, where there are chances of mixedinfection please recommend Arteplus/CD.

  • 8/4/2019 Anti Malarials

    14/50

    Condition

    Region is endemic for malaria.

    Chloroquine resistant strains of P.vivaxand P.falciparum are seen in the region.

    More cases of malaria were due tofalciparum.

    Prevailing sulphur drug sensitivity in theregion

  • 8/4/2019 Anti Malarials

    15/50

    Situation-2Sulfa + Pyri in CQ resistant vivax &

    uncomplicated falciparum malaria.

    Patient concern :-

    Patientis having high grade fever withmoderate chills.

    Rigors along with vomiting and malaise

    Feeling of weakness ,loss of appetite

  • 8/4/2019 Anti Malarials

    16/50

    Therapeutic needs

    Instant relief from fever and rigors

    Prevention of recrudescence.

    To prevent the infection from becomingsevere

  • 8/4/2019 Anti Malarials

    17/50

    Focus point

    To provide relief from fever and othersymptoms of malaria.

    To prevent recrudescence of the infectionin falciparum malaria.

  • 8/4/2019 Anti Malarials

    18/50

    Call objective

    To convert Sulfadoxine - PyrimethamineRxer to Arteplus/ CD in CQ resistant vivaxand uncomplicated falciparum malaria.

  • 8/4/2019 Anti Malarials

    19/50

    Need identification

    How frequently do you come across CQresistant malaria cases?

    What is your drug of choice in suchcases?

    Are you looking for a drug which can beused empirically for CQ resistant as wellas uncomplicated falciparum malaria?

  • 8/4/2019 Anti Malarials

    20/50

    Benefit presentation

    Dr. this article was published inParassitolgia 2004. In this article WHOhas recommended the use of AL in all the

    countries experiencing resistance toconventional therapies like CQ orsulfadoxine/pyrimethamine.

  • 8/4/2019 Anti Malarials

    21/50

    Benefit presentation

    Dr. this article was published in Americanjournal of tropical hygiene,2007. Thisstudy was conducted on 99 Nepalese

    patients with uncomplicated falciparummalaria.

    Conclusion :- AL was found to be more

    effective than SP for uncomplicatedFalciparum malaria.

  • 8/4/2019 Anti Malarials

    22/50

    Feedback

    What is your opinion regarding the use ofArteplus /CD in CQ resistant oruncomplicated falciparum malaria cases?

  • 8/4/2019 Anti Malarials

    23/50

    Commitment

    Dr. in coming 5 cases of CQ resistant anduncomplicated malaria cases, pleaserecommend Arteplus /CD.

  • 8/4/2019 Anti Malarials

    24/50

    Condition

    Drs using plain artemisinin compound in

    the treatment of uncomplicated falciparummalaria.

    Incidences of resistance against CQ andother antimalarials are on a rise.

  • 8/4/2019 Anti Malarials

    25/50

    Situation 3

    Artemether tab in uncomplicated

    Falciparum malaria.

    Patient concern:-

    Patient is having high grade fever withmoderate chills.

    Rigors along with vomiting and malaise

    Feeling of weakness Loss of appetite

  • 8/4/2019 Anti Malarials

    26/50

    Therapeutic needs

    To reduce FCT & PCT

    To prevent recrudescence of the infection

    Prevention of the emergence of theresistance

  • 8/4/2019 Anti Malarials

    27/50

    Focus point

    To provide relief from fever and othersymptoms of malaria.

    To prevent recrudescence of the infectionin falciparum malaria.

    To prevent emergence of resistanceagainst other antimalarials.

  • 8/4/2019 Anti Malarials

    28/50

    Call objective

    To convert plain artemether Rxer toArteplus / CD or Falcigo plus inuncomplicated falciparum malaria.

  • 8/4/2019 Anti Malarials

    29/50

    Need identification

    What is your line of treatment in Uncomplicatedfalciparum malaria ?

    How frequently do you see the infection

    reappearance in such cases even after thetreatment with plain artemisinin compound?

    In such cases are you looking for a drug whichwill not only help in preventing recrudescencebut will also reduce the likelihood of emergenceof resistance against other antimalarials?

  • 8/4/2019 Anti Malarials

    30/50

    Benefit presentation

    Dr. this study was published in Expertopinion on investigational drugs, 2000. Itsuggests that Artemisinin compounds like

    Artemetheror Artesunateshould becombined with long acting antimalarialslike Lumefantrineor Mefloquine to prevent

    recrudescence, to improve complianceand to prevent progression of resistanceagainst antimalarials.

  • 8/4/2019 Anti Malarials

    31/50

    Feedback

    How well do you think that Arteplus /CDorFalcigo pluscan help you in preventing therecrudescence, the emergence of

    resistance and faster resolution ofsymptoms in uncomplicated falciparummalaria ?

  • 8/4/2019 Anti Malarials

    32/50

    Commitment

    Dr. In your forthcoming patients sufferingfrom uncomplicated falciparum malariadepend on Arteplus /CD for the prevention

    of recrudescence, emergence ofresistance and faster resolution ofsymptoms.

  • 8/4/2019 Anti Malarials

    33/50

    Condition

    Endemic region for malaria

    Resistant strains of vivax and falciparumare common in the region.

    Several deaths were reported due tomalaria

  • 8/4/2019 Anti Malarials

    34/50

    Situation-5Arteether /Artemether Inj.

    In Severe malaria

    Patient is having high grade fever with

    chills. Severe headache and fatigue

    Respiratory distress.

    Jaundice Unconscious

  • 8/4/2019 Anti Malarials

    35/50

    Therapeutic needs

    Save the life of the patient.

    To prevent other complications.

    Faster clearance of the parasite from theblood.

    To maintain high and sustainedconcentration of the drug in the blood toprevent recrudescence and to preventresistance development.

  • 8/4/2019 Anti Malarials

    36/50

    Focus point

    To save the life of the patient by havingprofound (fast and long) action of the drug.

    To prevent further complications like organdamage.

  • 8/4/2019 Anti Malarials

    37/50

    Call objective

    To convert plain artemether /arteetherRxer to Falcigo Inj. in severe malaria.

  • 8/4/2019 Anti Malarials

    38/50

    Need identification

    What are the objectives of treatment insevere falciparum malaria ?

    Which are the important parameters youare looking in for while Rxing a drug insuch cases ?

    How important is the quick absorption and

    safety of the drug in such situations?

  • 8/4/2019 Anti Malarials

    39/50

    Benefit presentation

    This article was published in New Englandjournal of medicine, 2008. This articleclearly states that the efficacy of the fat

    soluble artemisinin compounds i.e.arteether & artemether in severe malaria islimited due to its varied absorption (they

    are given IM). Artesunate is having morereliable pharmacokinetic profile as it iswater soluble(given IV).

  • 8/4/2019 Anti Malarials

    40/50

    Benefit presentation

    Dr. the same study speaks about thesafety profile of AS as fat solubleartemisinins were found to be more

    neurotoxic as compared to AS.

    AS dosage need not be changed inhepatic and renal failure cases.

    No drug interaction is seen so far with AS.

  • 8/4/2019 Anti Malarials

    41/50

    Feedback

    How well do you think that Falcigo canhelp you in saving the life and preventingfurther complications in severe falciparum

    malaria ?

  • 8/4/2019 Anti Malarials

    42/50

    Commitment

    Dr. In your forthcoming patients sufferingfrom severe malaria, depend on Falcigoinj. & tab for saving the life and preventing

    further complications.

  • 8/4/2019 Anti Malarials

    43/50

    Condition

    Endemic region for malaria.

    Many deaths has happened due to malaria

    Mostly P.falciparum was seen to beresponsible for causing malaria.

    MDR strains of falciparum are common inthe region.

  • 8/4/2019 Anti Malarials

    44/50

    Situation-6Quinine Inj. In Severe malaria

    High grade fever.

    Severe headache and fatigue Respiratory distress/ Dyspnea.

    Jaundice

    Unconscious

  • 8/4/2019 Anti Malarials

    45/50

    Focus point

    To save the life of the patient

    To prevent further complications like organdamage.

  • 8/4/2019 Anti Malarials

    46/50

    Call objective

    To convert plain Quinine Rxer to FalcigoInj. in severe malaria.

  • 8/4/2019 Anti Malarials

    47/50

    Need identification

    What are the objectives of treatment insevere falciparum malaria ?

    Which are the important parameters youare looking in for while Rxing a drug insuch cases ?

    How important is the risk reduction of

    death and safety of the drug in suchsituations?

  • 8/4/2019 Anti Malarials

    48/50

    Benefit presentation

    This article was published in New Englandjournal of medicine, 2008. This articleclearly states that risk reduction of death

    was 34.7% more with AS as comparedwith Quinine.

    Artesunate was found to be having leastside effects unlike Quinine havinghypoglycemia, visual disturbances andtinnitus as common one.

  • 8/4/2019 Anti Malarials

    49/50

    Feedback

    How well do you think that Falcigo canhelp you in saving the life and preventingfurther complications in severe falciparum

    malaria ?

  • 8/4/2019 Anti Malarials

    50/50

    Commitment

    Dr. In your forthcoming patients sufferingfrom severe malaria, depend on Falcigoinj. & tab for saving the life and preventing

    further complications.